Genetics of endocrine disease: The genetics of autoimmune thyroid disease

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 12, 2002, Pages 5385-5397

  Vaidya, Bijayeswar ^a   Kendall Taylor, Pat ^a   Pearce, Simon H S ^a,b,c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c INSTITUTE OF HUMAN GENETICS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOME DISORDER; DISEASE ASSOCIATION; GENETIC LINKAGE; HASHIMOTO DISEASE; HEREDITY; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MEDICAL GENETICS; PRIORITY JOURNAL; REVIEW; AUTOIMMUNE DISEASE; GENETIC PREDISPOSITION; GENETICS; MOLECULAR BIOLOGY; THYROID DISEASE;

ABATACEPT; ANTIBODY CONJUGATE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; AUTOIMMUNE DISEASES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOCONJUGATES; LINKAGE (GENETICS); MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR BIOLOGY; THYROID DISEASES;

EID: 0036884048     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-020492     Document Type: Review

References (205)

1. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA 1977 The spectrum of thyroid disease in a community: The Whickham survey. Clin Endocrinol (Oxf) 7:481-493
2. Canaris GJ, Manowitz NR, Mayor GM, Ridgway EC 2000 The Colorado thyroid disease prevalence study. Arch Int Med 160:526-534
3. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE 2002 Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489-499
4. Vestergaard P 2002 Smoking and thyroid disorders-a meta-analysis. Eur J Endocrinol 146:153-161
5. Winsa B, Adami HO, Bergstrom R, Gamstedt A, Dahlberg PA, Adamson U, Jansson R, Karlsson A 1991 Stressful life events and Graves' disease. Lancet 338:1475-1479
6. Sonino N, Girelli ME, Boscaro M, Fallo F, Busnardo B, Fava GA 1993 Life events in the pathogenesis of Graves' disease. A controlled study. Acta Endocrinol (Copenh) 128:293-296
7. Okayasu I, Kong YM, Rose NR 1981 Effect of castration and sex hormones on experimental autoimmune thyroiditis. Clin Immunol Immunopathol 20:240-245
8. Tomer Y, Davies TF 1993 Infection, thyroid disease, and autoimmunity. Endocr Rev 14:107-120
9. Brix TH, Kyvik KO, Christensen K, Hegedus L 2001 Evidence for a major role of heredity in Graves' disease: A population-based study of two Danish twin cohorts. J Clin Endocrinol Metab 86:930-934
10. Bartels ED 1941 Heredity in Graves' Disease, PhD thesis, Einar Munksgaard, Copenhagen
11. Harvald B, Hauge M 1956 A catamnestic investigation of Danish twins. Dan Med Bull 3:150-158
12. Vershuer OV 1958 Die zwillingsforschung im dienste der inneren medizin. Verh Dtsch Ges Inn Med 64:262-273
13. Brix TH, Kyvik KO, Hegedus L 2000 A population-based study of chronic autoimmune hypothyroidism in Danish twins. J Clin Endocrinol Metab 85:536-539
14. Wild RB 1886 Exophthalmic goitre: Familial predisposition. Br Med J 1:1021
15. Mackenzie H 1916 Exophthalmic goitre. Lancet ii:815-821
16. Gardiner-Hill H 1934 Heredity in cretinism, simple and toxic goitre. In: Blacker CP, ed. The chances of morbid inheritance. London: HK Lewis
17. Martin L, Fisher RA 1945 The hereditary and familial aspects of exophthalmic goitre and nodular goitre. Quart J Med 14:207-219
18. Howel-Evans AW, Woodrow JC, McDougal CDM, Chew AR, Evans RW 1967 Antibodies in the families of thyrotoxic patients. Lancet 1:636-641
19. Brix TH, Kyvik KO, Hegedus L 1998 What is the evidence of genetic factors in the etiology of Graves' disease? A brief review. Thyroid 8:627-634
20. Stenszky V, Kozma L, Balazs C, Rochlitz S, Bear JC, Farid NR 1985 The genetics of Graves' disease: HLA and disease susceptibility. J Clin Endocrinol Metab 61:735-740
21. Wandstrat A, Wakeland E 2001 The genetics of complex autoimmune diseases: Non-MHC susceptibility genes. Nature Immunol 2:802-809
22. Roitt IM, Doniach D, Campbell PN, Hudson RV 1956 Auto-antibodies in Hashimoto's disease (lymphadenoid goitre). Lancet ii:820-821
23. Hall R, Owen SG, Smart GA 1960 Evidence for a genetic predisposition to formation of thyroid autoantibodies. Lancet ii:187-188
24. Hall R, Saxena KM, Owen SG 1962 A study of the parents of patients with Hashimoto's disease. Lancet ii:1291-1292
25. Phillips D, McLachlan S, Stephenson A, Roberts D, Moffitt S, McDonald D, Ad'Hiah A, Stratton A, Young E, Clark F 1990 Autosomal dominant transmission of autoantibodies to thyroglobulin and thyroid peroxidase. J Clin Endocrinol Metab 70:742-746
26. Phillips D, Prentice L, Upadhyaya M, Lunt P, Chamberlain S, Roberts DF, McLachlan S, Smith BR 1991 Autosomal dominant inheritance of autoantibodies to thyroid peroxidase and thyroglobulin-studies in families not selected for autoimmune thyroid disease. J Clin Endocrinol Metab 72:973-975
27. Jaume JC, Guo J, Pauls DL, Zakarija M, McKenzie JM, Egeland JA, Burek CL, Rose NR, Hoffman WH, Rapoport B, McLachlan SM 1999 Evidence for genetic transmission of thyroid peroxidase autoantibody epitopic "fingerprints". J Clin Endocrinol Metab 84:1424-1431
28. Heward J, Gough SCL 1997 Genetic susceptibility to the development of autoimmune disease. Clin Sci (Lond) 93:479-491
29. Payami H, Joe S, Thomson G 1989 Autoimmune thyroid disease in type 1 diabetic families. Genet Epidemiol 6:137-141
30. Torfs CP, King MC, Huey B, Malmgren J, Grumet FC 1986 Genetic interrelationship between insulin-dependent diabetes mellitus, the autoimmune thyroid diseases, and rheumatoid arthritis. Am J Hum Genet 38:170-187
31. Walker DJ, Griffiths M, Griffiths ID 1986 Occurrence of autoimmune diseases and autoantibodies in multicase rheumatoid arthritis families. Ann Rheum Dis 45:323-326
32. Grennan DM, Dyer PA, Clague R, Dodds W, Smeaton I, Harris R 1983 Family studies in RA-the importance of HLA-DR4 and of genes for autoimmune thyroid disease. J Rheumatol 10:584-589
33. Nerup J 1974 Addison's disease: Clinical studies. A report of 108 cases. Acta Endocrinol (Copenh) 76:127-141
34. Vaidya B, Imrie H, Geatch DR, Perros P, Ball SG, Baylis PH, Carr D, Hurel SJ, James RA, Kelly WF, Kemp EH, Young ET, Weetman AP, Kendall-Taylor P, Pearce SH 2000 Association analysis of the cytotoxic T lymphocyte antigen-4 and autoimmune regulator-1 genes in sporadic autoimmune Addison's disease. J Clin Endocrinol Metab 85:688-691
35. Broadley SA, Deans J, Sawcer SJ, Clayton D, Compston DAS 2000 Autoimmune disease in first-degree relatives of patients with multiple sclerosis. Brain 123:1102-1111
36. Pearce SHS, Cheetham TD 2001 Autoimmune polyendocrinopathy type 1: Treat with kid gloves. Clin Endocrinol (Oxf) 54:433-435
37. Perheentupa J 2002 APS-I/APECED: The clinical disease and therapy. Endocrinol Metab Clin North Am 31:295-320
38. Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, Krohn KJ, Lalioti MD, Mullis PE, Antonarakis SE, Kawasaki K, Asakawa S, Ito F, Shimizu N 1997 Positional cloning of the APECED gene. Nat Genet 17:393-398
39. Powell BR, Buist NR, Stenzel P 1982 An X-linked syndrome of diarrhoea, polyendocrinopathy, and fatal infection in infancy. J Pediatr 100:731-737
40. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, Levy-Lahad E, Mazzella M, Goulet O, Perroni L, Bricarelli FD, Byrne G, McEuen M, Proll S, Appleby M, Brunkow ME 2001 X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27:18-20
41. Karlsson B, Gustafsson J, Hedov G, Ivarsson SA, Anneren G 1998 Thyroid dysfunction in Down's syndrome: Relation to age and thyroid autoimmunity. Arch Dis Child 79:242-245
42. Friedman DL, Kastner T, Pond WS, O'Brien DR 1989 Thyroid dysfunction in individuals with Down syndrome. Arch Intern Med 149:1990-1993
43. Murdoch JC, Ratcliffe WA, McLarty DG, Rodger JC, Ratcliffe JG 1977 Thyroid function in adults with Down's syndrome. J Clin Endocrinol Metab 44:453-458
44. Medeiros CC, Marini SH, Baptista MT, Guerra Jr G, Maciel-Guerra AT 2000 Turner's syndrome and thyroid disease: A transverse study of pediatric patients in Brazil. J Pediatr Endocrinol Metab 13:357-362
45. Elsheikh M, Wass JA, Conway GS 2001 Autoimmune thyroid syndrome in women with Turner's syndrome-the association with karyotype. Clin Endocrinol (Oxf) 55:223-226
46. Radetti G, Mazzanti L, Paganini C, Bernasconi S, Russo G, Rigon F, Cacciari E 1995 Frequency, clinical and laboratory features of thyroiditis in girls with Turner's syndrome. Acta Paediatr 84:909-912
47. de Kerdanet M, Lucas J, Lemee F, Lecornu M 1994 Turner's syndrome with X-isochromosome and Hashimoto's thyroiditis. Clin Endocrinol (Oxf) 41:673-676
48. Sparkes RS, Motulsky AG 1967 The Turner syndrome with isochromosome X and Hashimoto's thyroiditis. Ann Intern Med 67:132-144
49. Kawame H, Adachi M, Tachibana K, Kurosawa K, Ito F, Gleason MM, Weinzimer S, Levitt-Katz L, Sullivan K, McDonald-McGinn DM 2001 Graves' disease in patients with 22q11.2 deletion. J Pediatr 139:892-895
50. Adachi M, Tachibana K, Masuno M, Makita Y, Maesaka H, Okada T, Hizukuri K, Imaizumi K, Kuroki Y, Kurahashi H, Suwa S 1998 Clinical characteristics of children with hypoparathyroidism due to 22q11.2 microdeletion. Eur J Pediatr 157:34-38
51. Kawamura T, Nimura I, Hanafusa M, Fujikawa R, Okubo M, Egusa G, Amakido M 2000 DiGeorge syndrome with Graves' disease: A case report. Endocr J 47:91-95
52. Lander ES, Schork NJ 1994 Genetic dissection of complex traits. Science 265:2037-2048
53. Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SC, Jenkins SC, Palmer SM, Balfour K, Rowe B, Farrall M, Barnett AH, Bain SC, Todd JA 1994 A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371:130-136
54. Mein CA, Esposito L, Dunn MG, Johnson GC, Timms AE, Goy JV, Smith AN, Sebag-Montefiore L, Merriman ME, Wilson AJ, Pritchard LE, Cucca F, Barnett AH, Bain SC, Todd JA 1998 A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nat Genet 19:297-300
55. Concannon P, Gogolin-Ewens KJ, Hinds DA, Wapelhorst B, Morrison VA, Stirling B, Mitra M, Farmer J, Williams SR, Cox NJ, Bell GI, Risch N, Spielman RS 1998 A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus. Nat Genet 19:292-296
56. Cox NJ, Wapelhorst B, Morrison VA, Johnson L, Pinchuk L, Spielman RS, Todd JA, Concannon P 2001 Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families. Am J Hum Genet 69:820-830
57. Vyse TJ, Todd JA 1996 Genetic analysis of autoimmune disease. Cell 85:311-318
58. Cornelis F, Faure S, Martinez M, Prud'homme JF, Fritz P, Dib C, Alves H, Barrera P, de Vries N, Balsa A, Pascual-Salcedo D, Maenaut K, Westhovens R, Migliorini P, Tran TH, Delaye A, Prince N, Lefevre C, Thomas G, Poirier M, Soubigou S, Alibert O, Lasbleiz S, Fouix S, Weissenbach J 1998 New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci USA 95:10746-10750
59. Shai R, Quismorio FP, Li L, Kwon OJ, Morrison J, Wallace DJ, Neuwelt CM, Brautbar C, Gauderman WJ, Jacob CO 1999 Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. Hum Mol Genet 8:639-644
60. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, Hinokio Y, Lindner TH, Mashima H, Schwarz PE, del Bosque-Plata L, Horikawa Y, Oda Y, Yoshiuchi I, Colilla S, Polonsky KS, Wei S, Concannon P, Iwasaki N, Schulze J, Baier LJ, Bogardus C, Groop L, Boerwinkle E, Hanis CL, Bell GI 2000 Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26:163-175
61. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G 2001 Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411:599-603
62. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH 2001 A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411:603-606
63. Grumet FC, Payne RO, Konishi J, Kriss JP 1974 HL-A antigens as markers for disease susceptibility and autoimmunity in Graves' disease. J Clin Endocrinol Metab 39:1115-1119
64. Seignalet J, Mirouze J, Jaffiol C, Selam JL, Lapinski H 1975 HL-A in Graves' disease and in diabetes mellitus insulin-dependent. Tissue Antigens 6:272-274
65. Farid NR, Barnard JM, Marshall WH 1976 The association of HLA with autoimmune thyroid disease in Newfoundland. The influence of HLA homozygosity in Graves' disease. Tissue Antigens 8:181-189
66. Bech K, Lumholtz B, Nerup J, Thomsen M, Platz P, Ryder LP, Svejgaard A, Siersbaek-Nielsen K, Hansen JM, Larsen JH 1977 HLA antigens in Graves' disease. Acta Endocrinol (Copenh) 86:510-516
67. Farid NR, Sampson L, Noel EP, Barnard JM, Mandeville R, Larsen B, Marshall WH, Carter ND 1979 A study of human leukocyte D locus related antigens in Graves' disease. J Clin Invest 63:108-113
68. Tomer Y, Davies TF 1997 The genetic susceptibility to Graves' disease. Baillieres Clin Endocrinol Metab 11:431-450
69. Gough SC 2000 The genetics of Graves' disease. Endocrinol Metab Clin North Am 29:255-266
70. Heward JM, Allahabadia A, Daykin J, Carr-Smith J, Daly A, Armitage M, Dodson PM, Sheppard MC, Barnett AH, Franklyn JA, Gough SC 1998 Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: Replication using a population case control and family-based study. J Clin Endocrinol Metab 83:3394-3397
71. Yanagawa T, Mangklabruks A, Chang YB, Okamoto Y, Fisfalen ME, Curran PG, DeGroot LJ 1993 Human histocompatability leukocyte antigenDQA1*0501 allele associated with genetic susceptibility to Graves' disease in a Caucasian population. J Clin Endocrinol Metab 76:1569-1574
72. Yanagawa T, Mangklabruks A, DeGroot LJ 1994. Strong association between HLA-DQA1*0501 and Graves' disease in a male Caucasian population. J Clin Endocrinol Metab 79:227-229
73. Barlow AB, Wheatcroft N, Watson P, Weetman AP 1996 Association of HLA-DQA1*0501 with Graves' disease in English Caucasian men and women. Clin Endocrinol (Oxf) 44:73-77
74. Maciel LM, Rodrigues SS, Dibbern RS, Navarro PA, Donadi EA 2001 Association of the HLA-DRB1*0301 and HLA-DQA1*0501 alleles with Graves' disease in a population representing the gene contribution from several ethnic backgrounds. Thyroid 11:31-35
75. Cuddihy RM, Bahn RS 1996 Lack of an independent association between the human leukocyte antigen allele DQA1*0501 and Graves' disease. J Clin Endocrinol Metab 81:847-849
76. Philippou G, Krimitzas A, Kaltsas G, Anastasiou E, Souvatzoglou A, Alevizaki M 2001 HLA DQA1*0501 and DRB1*0301 antigens do not independently convey susceptibility to Graves' disease. J Endocrinol Invest 24:88-91
77. Hunt PJ, Marshall SE, Weetman AP, Bunce M, Bell JI, Wass JA, Welsh KI 2001 Histocompatibility leucocyte antigens and closely linked immunomodulatory genes in autoimmune thyroid disease. Clin Endocrinol (Oxf) 55:491-499
78. Zamani M, Spaepen M, Bex M, Bouillon R, Cassiman J-J 2000 Primary role of the HLA Class II DRB1*0301 allele in Graves disease. Am J Med Genet 95:432-437
79. Kawa A, Nakamura S, Nakazawa M, Sakaguchi S, Kawabata T, Maeda Y, Kanehisa T 1977 HLA-BW35 and B5 in Japanese patients with Graves' disease. Acta Endocrinol (Copenh) 86:754-757
80. Dong RP, Kimura A, Okubo R, Shinagawa H, Tamai H, Nishimura Y, Sasazuki T 1992 HLA-A and DPB1 loci confer susceptibility to Graves' disease. Hum Immunol 35:165-172
81. Onuma H, Ota M, Sugenoya A, Inoko H 1994 Association of HLA-DPB1*0501 with early-onset Graves' disease in Japanese. Hum Immunol 39:195-201
82. Tandon N, Mehra NK, Taneja V, Vaidya MC, Kochupillai N 1990 HLA antigens in Asian Indian patients with Graves' disease. Clin Endocrinol (Oxf) 33:21-26
83. Omar MA, Hammond MG, Desai RK, Motala AA, Aboo N, Seedat MA 1990 HLA class I and II antigens in South African blacks with Graves' disease. Clin Immunol Immunopathol 54:98-102
84. Chen QY, Nadell D, Zhang XY, Kukreja A, Huang YJ, Wise J, Svec F, Richards R, Friday KE, Vargas A, Gomez R, Chalew S, Lan MS, Tomer Y, Maclaren NK 2000 The human leukocyte antigen HLA DRB3*020/DQA1*0501 haplotype is associated with Graves' disease in African Americans. J Clin Endocrinol Metab 85:1545-1549
85. Wong GW, Cheng SH, Dorman JS 1999 The HLA-DQ associations with Graves' disease in Chinese children. Clin Endocrinol (Oxf) 50:493-495
86. Cavan DA, Penny MA, Jacobs KH, Kelly MA, Jenkins D, Mijovic C, Chow C, Cockram CS, Hawkins BR, Barnett AH 1994 The HLA association with Graves' disease is sex-specific in Hong Kong Chinese subjects. Clin Endocrinol (Oxf) 40:63-66
87. Ratanachaiyavong S, Demaine AG, Campbell RD, McGregor AM 1991 Heat shock protein 70 (HSP70) and complement C4 genotypes in patients with hyperthyroid Graves' disease. Clin Exp Immunol 84:48-52
88. Badenhoop K, Schwarz G, Schleusener H, Weetman AP, Recks S, Peters H, Bottazzo GF, Usadel KH 1992 Tumor necrosis factor β gene polymorphisms in Graves' disease. J Clin Endocrinol Metab 74:287-291
89. Rau H, Nicolay A, Donner H, Usadel KH, Badenhoop K 1997 Polymorphisms of TAP1 and TAP2 genes in German patients with type 1 diabetes mellitus. Eur J Immunogenet 24:229-236
90. Heward JM, Allahabadia A, Sheppard MC, Barnett H, Franklyn JA, Gough SCL 1999 Association of the large multifunctional proteasome (LMP2) gene with Graves' disease is a result of linkage disequilibrium with the HLA haplotype DRB1*0304-DQB1*02-DQA1*0501. Clin Endocrinol (Oxf) 51:115-118
91. Kamizono S, Hiromatsu Y, Seki N, Bednarczuk T, Matsumoto H, Kimura A, Itoh K 2000 A polymorphism of the 5′ flanking region of tumour necrosis factor α gene is associated with thyroid-associated ophthalmopathy in Japanese. Clin Endocrinol (Oxf) 52:759-764
92. Farid NR, Stone E, Johnson G 1980 Graves' disease and HLA: Clinical and epidemiologic associations. Clin Endocrinol (Oxf) 13:535-544
93. Schleusener H, Schernthaner G, Mayr WR, Kotulla P, Bogner U, Finke R, Meinhold H, Koppenhagen K, Wenzel KW 1983 HLA-DR3 and HLA-DR5 associated thyrotoxicosis-two different types of toxic diffuse goitre. J Clin Endocrinol Metab 56:781-785
94. Frecker M, Stenszky V, Balazs C, Kozma L, Kraszits E, Farid NR 1986 Genetic factors in Graves' ophthalmopathy. Clin Endocrinol (Oxf) 25:479-485
95. Kendall-Taylor P, Stephenson A, Stratton A, Papiha SS, Perros P, Roberts DF 1988 Differentiation of autoimmune ophthalmopathy from Graves' hyperthyroidism by analysis of genetic markers. Clin Endocrinol (Oxf) 28:601-610
96. Weetman AP, So AK, Warner CA, Foroni L, Fells P, Shine B 1988 Immunogenetics of Graves' ophthalmopathy. Clin Endocrinol (Oxf) 28:619-628
97. Allahabadia A, Heward JM, Nithiyananthan R, Gibson SM, Reuser TT, Dodson PM, Franklyn JA, Gough SC 2001 MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease. Lancet 358:984-985
98. Frecker M, Mercer G, Skanes VM, Farid NR 1988 Major histocompatibility complex (MHC) factors predisposing to and protecting against Graves' eye disease. Autoimmunity 1:307-315
99. Farid NR 1987 Immunogenetics of autoimmune thyroid disorders. Endocrinol Metab Clin North Am 16:229-245
100. McGregor AM, Smith BR, Hall R, Petersen MM, Miller M, Dewar PJ 1980 Prediction of relapse in hyperthyroid Graves' disease. Lancet 1:1101-1103
101. Allannic H, Fauchet R, Lorcy Y, Gueguen M, Le Guerrier AM, Genetet B 1983 A prospective study of the relationship between relapse of hyperthyroid Graves' disease after antithyroid drugs and HLA haplotype. J Clin Endocrinol Metab 57:719-722
102. de Bruin TW, Bolk JH, Bussemaker JK, Stijnen T, Schreuder GM, de Vries RR, van der Heide D 1988 Graves' disease: Immunological and immunogenetic indicators of relapse. Br Med J 296:1292-1295
103. Young ET, Steel NR, Taylor JJ, Stephenson AM, Stratton A, Holcombe M, Kendall-Taylor P 1988 Prediction of remission after antithyroid drug treatment in Graves' disease. Q J Med 66:175-189
104. Weetman AP, Pickerill AP, Watson P, Chatterjee VK, Edwards OM 1994 Treatment of Graves' disease with the block-replace regimen of antithyroid drugs: The effect of treatment duration and immunogenetic susceptibility on relapse. Q J Med 87:337-341
105. Farid NR 1981 Graves' disease. In: Farid NR, ed. HLA in Endocrine and Metabolic Disorders. New York: Academic Press; 85-143
106. Tamai H, Sudo T, Kimura A, Mukuta T, Matsubayashi S, Kuma K, Nagataki S, Sasazuki T 1996 Association between the DRB1*08032 histocompatibility antigen and methimazole-induced agranulocytosis in Japanese patients with Graves disease. Ann Intern Med 124:490-494
107. Irvine WJ, Gray RS, Morris PJ, Ting A 1978 HLA in primary atrophic hypothyroidism and Hashimoto goitre. J Clin Lab Immunol 1:193-195
108. Moens H, Farid NR, Sampson L, Noel EP, Barnard JM 1978 Hashimoto's thyroiditis is associated with HLA-DRw3. N Engl J Med 299:133-134
109. Tandon N, Zhang L, Weetman AP 1991 HLA associations with Hashimoto's thyroiditis. Clin Endocrinol (Oxf) 34:383-386
110. Thompson C, Farid NR 1985 Post-partum thyroiditis and goitrous (Hashimoto's) thyroiditis are associated with HLA-DR4. Immunol Lett 11:301-303
111. Petrone A, Giorgi G, Mesturino CA, Capizzi M, Cascino I, Nistico L, Osborn J, Di Mario U, Buzzetti R 2001 Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in an Italian population. Thyroid 11:171-175
112. Weissel M, Hofer R, Zasmeta H, Mayr WR 1980 HLA-DR and Hashimoto's thyroiditis. Tissue Antigens 16:256-257
113. Bogner U, Badenhoop K, Peters H, Schmieg D, Mayr WR, Usadel KH, Schleusener H 1992 HLA-DR/DQ gene variation in nongoitrous autoimmune thyroiditis at the serological and molecular level. Autoimmunity 14:155-158
114. Badenhoop K, Schwarz G, Walfish PG, Drummond V, Usadel KH, Bottazzo GF 1990 Susceptibility to thyroid autoimmune disease: Molecular analysis of HLA-D region genes identifies new markers for goitrous Hashimoto's thyroiditis. J Clin Endocrinol Metab 71:1131-1137
115. Lervang HH, Pyrds O, Kristensen HP, Jakobsen BK, Svejgaard A 1984 Postpartum autoimmune thyroid disorder associated with HLA-DR4? Tissue Antigens 23:250-252
116. Jansson R, Safwenberg J, Dahlberg PA 1985 Influence of the HLA-DR4 antigen and iodine status on the development of autoimmune postpartum thyroiditis. J Clin Endocrinol Metab 60:168-173
117. Pryds O, Lervang HH, Kristensen HP, Jakobsen BK, Svejgaard A 1987 HLA-DR factors associated with postpartum hypothyroidism: An early manifestation of Hashimoto's thyroiditis? Tissue Antigens 30:34-37
118. Vargas MT, Briones-Urbina R, Gladman D, Papsin FR, Walfish PG 1988 Antithyroid microsomal autoantibodies and HLA-DR5 are associated with postpartum thyroid dysfunction: Evidence supporting an autoimmune pathogenesis. J Clin Endocrinol Metab 67:327-333
119. Parkes AB, Darke C, Othman S, Thomas M, Young N, Richards CJ, Hall R, Lazarus JH 1996 Major histocompatibility complex class II and complement polymorphisms in postpartum thyroiditis. Eur J Endocrinol 134:449-453
120. Uno H, Sasazuki T, Tamai H, Matsumoto H 1981 Two major genes, linked to HLA and Gm, control susceptibility to Graves' disease. Nature 292:768-770
121. Tamai H, Uno H, Hirota Y, Matsubayashi S, Kuma K, Matsumoto H, Kumagai LF, Sasazuki T, Nagataki S 1985 Immunogenetics of Hashimoto's and Graves' diseases. J Clin Endocrinol Metab 60:62-66
122. Payami H, Joe S, Farid NR, Stenszky V, Chan SH, Yeo PP, Cheah JS, Thomson G 1989 Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. Am J Hum Genet 45:541-546
123. Roman SH, Greenberg D, Rubinstein P, Wallenstein S, Davies TF 1992 Genetics of autoimmune thyroid disease: Lack of evidence for linkage to HLA within families. J Clin Endocrinol Metab 74:496-503
124. O'Connor G, Neufeld DS, Greenberg DA, Concepcion ES, Roman SH, Davies TF 1993 Lack of disease associated HLA-DQ restriction fragment length polymorphisms in families with autoimmune thyroid disease. Autoimmunity 14:237-241
125. Shields DC, Ratanachaiyavong S, McGregor AM, Collins A, Morton NE 1994 Combined segregation and linkage analysis of Graves disease with a thyroid autoantibody diathesis. Am J Hum Genet 55:540-554
126. Tomer Y, Barbesino G, Keddache M, Greenberg DA, Davies TF 1997 Mapping of a major susceptibility locus for Graves' disease (GD-1) to chromosome 14q31. J Clin Endocrinol Metab 82:1645-1648
127. Vaidya B, Imrie H, Perros P, Young ET, Kelly WF, Carr D, Large DM, Toft AD, McCarthy MI, Kendall-Taylor P, Pearce SHS 1999 The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus. Hum Mol Genet 8:1195-1199
128. Tomer Y, Barbesino G, Greenberg DA, Concepcion ES, Davies TF 1999 Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: Evidence for genetic heterogeneity and gene interactions. J Clin Endocrinol Metab 84:4656-4664
129. Sakai K, Shirasawa S, Ishikawa N, Ito K, Tamai H, Kuma K, Akamizu T, Tanimura M, Furugaki K, Yamamoto K, Sasazuki T 2001 Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoro's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese. Hum Mol Genet 10:1379-1386
130. Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, Thompson CB, Griesser H, Mak TW 1995 Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270:985-988
131. Perrin PJ, Maldonado JH, Davis TA, June CH, Racke MK 1996 CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. J Immunol 157:1333-1336
132. Luhder F, Hoglund P, Allison JP, Benoist C, Mathis D 1998 Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. J Exp Med 187:427-432
133. Lenschow DJ, Ho SC, Sattar H, Rhee L, Gray G, Nabavi N, Herold KC, Bluestone JA 1995 Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med 181:1145-1155
134. Krummel MF, Allison JP 1996 CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med 183:2533-2540
135. Gribben JG, Freeman GJ, Boussiotis VA, Rennert P, Jellis CL, Greenfield E, Barber M, Restivo Jr VA, Ke X, Gray GS 1995 CTLA4 mediates antigen-specific apoptosis of human T cells. Proc Natl Acad Sci USA 92:811-815
136. Scheipers P, Reiser H 1998 Fas-independent death of activated CD4(+) T lymphocytes induced by CTLA-4 crosslinking. Proc Natl Acad Sci USA 95:10083-10088
137. Johnson GC, Esposito L, Barratt BJ, Smith AN, Heward J, Di Genova G, Ueda H, Cordell HJ, Eaves IA, Dudbridge F, Twells RC, Payne F, Hughes W, Nutland S, Stevens H, Carr P, Tuomilehto-Wolf E, Tuomilehto J, Gough SC, Clayton DG, Todd JA 2001 Haplotype tagging for the identification of common disease genes. Nat Genet 29:233-237
138. Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, DeGroot LJ 1995 CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab 80:41-45
139. Huang D, Giscombe R, Zhou Y, Pirskanen R, Lefvert AK 2000 Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyper-reactivity via the CD28 pathway in myasthenia gravis. J Neuroimmunol 105:69-77
140. Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ 2000 CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol 165:6606-6611
141. Ligers A, Teleshova N, Masterman T, Huang WX, Hillert J 2001 CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2:145-152
142. Holopainen PM, Partanen JA 2001 Technical note: Linkage disequilibrium and disease-associated CTLA4 gene polymorphisms. J Immunol 167:2457-2458
143. Nisticò L, Nistico L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E, Larrad MT, Rios MS, Chow CC, Cockram CS, Jacobs K, Mijovic C, Bain SC, Barnett AH, Vandewalle CL, Schuit F, Gorus FK, Tosi R, Pozzilli P, Todd JA 1996 The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum Mol Genet 5:1075-1080
144. Kotsa K, Watson PF, Weetman AP 1997 A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism. Clin Endocrinol (Oxf) 46:551-554
145. Sale MM, Akamizu T, Howard TD, Yokota T, Nakao K, Mort T, Iwasaki H, Rich SS, Jennings-Gee JE, Yamada M, Bowden DW 1997 Association of autoimmune thyroid disease with a microsatellite marker for the thyrotropin receptor gene and CTLA-4 in a Japanese population. Proc Assoc Am Physicians 109:453-461
146. Akamizu T, Sale MM, Rich SS, Hiratani H, Noh JY, Kanamoto N, Saijo M, Miyamoto Y, Saito Y, Nakao K, Bowden DW 2000 Association of autoimmune thyroid disease with microsatellite markers for the thyrotropin receptor gene and CTLA-4 in Japanese patients. Thyroid 10:851-858
147. Hadj Kacem H, Bellassoued M, Bougacha-Elleuch N, Abid M, Ayadi H 2001 CTLA-4 gene polymorphisms in Tunisian patients with Graves' disease. Clin Immunol 101:361-365
148. Donner H, Rau H, Walfish PG, Braun J, Siegmund T, Finke R, Herwig J, Usadel KH, Badenhoop K 1997 CTLA4 Alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 82:143-146
149. Yanagawa T, Taniyama M, Enomoto S, Gomi K, Maruyama H, Ban Y, Saruta T 1997 CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese. Thyroid 7:843-846
150. Awata T, Kurihara S, Iitaka M, Takei S, Inoue I, Ishii C, Negishi K, Izumida T, Yoshida Y, Hagura R, Kuzuya N, Kanazawa Y, Katayama S 1998 Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population. Diabetes 47:128-129
151. Djilali-Saiah I, Larger E, Harfouch-Hammoud E, Timsit J, Clerc J, Bertin E, Assan R, Boitard C, Bach JF, Caillat-Zucman S 1998 No major role for the CTLA-4 gene in the association of autoimmune thyroid disease with 1DDM. Diabetes 47:125-127
152. Heward JM, Allahabadia A, Armitage M, Hattersley A, Dodson PM, Macleod K, Carr-Smith J, Daykin J, Daly A, Sheppard MC, Holder RL, Barnett AH, Franklyn JA, Gough SC 1999 The development of Graves' disease and the CTLA-4 gene on chromosome 2q33.J Clin Endocrinol Metab 84:2398-2401
153. Agarwal K, Czaja AJ, Jones DE, Donaldson PT 2000 Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. Hepatology 31:49-53
154. Vaidya B, Imrie H, Perros P, Dickinson J, McCarthy MI, Kendall-Taylor P, Pearce SHS 1999 Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy. Lancet 354:743-744
155. Buzzetti R, Nisticò L, Signore A, Cascino I 1999 CTLA-4 and HLA gene susceptibility to thyroid-associated orbitopathy. Lancet 354:1824
156. Villanueva R, Inzerillo AM, Tomer Y, Barbesino G, Meltzer M, Concepcion ES, Greenberg DA, MacLaren N, Sun ZS, Zhang DM, Tucci S, Davies TF 2000 Limited genetic susceptibility to severe Graves' ophthalmopathy: No role for CTLA-4 but evidence for an environmental etiology. Thyroid 10:791-798
157. Park YJ, Chung HK, Park DJ, Kim WB, Kim SW, Koh JJ, Cho BY 2000 Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans. Thyroid 10:453-459
158. Zaletel K, Krhin B, Gaberscek S, Pirnat E, Hojker S 2002 The influence of the exon 1 polymorphism of the cytotoxic T lymphocyte antigen 4 gene on thyroid antibody production in patients with newly diagnosed Graves' disease. Thyroid 12:373-376
159. Vaidya B, Pearce SH, Charlton S, Marshall N, Rowan AD, Griffiths ID, Kendall-Taylor P, Cawston TE, Young-Min S 2002 An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies. Rheumatology 41:180-183
160. Chistyakov DA, Savost'anov KV, Turakulov RI, Petunina NA, Trukhina LV, Kudinova AV, Balabolkin MI, Nosikov VV 2000 Complex association analysis of Graves disease using a set of polymorphic markers. Mol Genet Metab 70:214-218
161. Braun J, Donner H, Siegmund T, Walfish PG, Usadel KH, Badenhoop K 1998 CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis. Tissue Antigens 51:563-566
162. Heward JM, Allahabadia A, Carr-Smith J, Daykin J, Cockram CS, Gordon C, Barnett AH, Franklyn JA, Gough SC 1998 No evidence for allelic association of a human CTLA-4 promoter polymorphism with autoimmune thyroid disease in either population-based case-control or family-based studies. Clin Endocrinol (Oxf) 49:331-334
163. Donner H, Braun J, Seidl C, Rao H, Finke R, Ventz M, Walfish PG, Usadel KH, Badenhoop K 1997 Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J
164. Nithiyananthan R, Heward JM, Allahabadia A, Franklyn JA, Gough SC 2002 Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom. Thyroid 12:3-6
165. Waterman EA, Watson PF, Lazarus JH, Parkes AB, Darke C, Weetman AP 1998 A study of the association between a polymorphism in the CTLA-4 gene and postpartum thyroiditis. Clin Endocrinol (Oxf) 49:251-255
166. Barbesino G, Tomer Y, Concepcion E, Davies TF, Greenberg DA 1998 Linkage analysis of candidate genes in autoimmune thyroid disease: 1. Selected immunoregulatory genes. J Clin Endocrinol Metab 83:3290-3295
167. Tomer Y, Greenberg DA, Barbesino G, Concepcion E, Davies TF 2001 CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. J Clin Endocrinol Metab 86:1687-1693
168. Marron MP, Raffel LJ, Garchon HJ, Jacob CO, Serrano-Rios M, Martinez Larrad MT, Teng WP, Park Y, Zhang ZX, Goldstein DR, Tao YW, Beaurain G, Bach JF, Huang HS, Luo DF, Zeidler A, Rotter JI, Yang MC, Modilevsky T, Maclaren NK, She JX 1997 Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet 6:1275-1282
169. Kemp EH, Ajjan RA, Husebye ES, Peterson P, Uibo R, Imrie H, Pearce SH, Watson PF, Weetman AP 1998 A cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients. Clin Endocrinol (Oxf) 49:609-613
170. Agarwal K, Jones DE, Daly AK, James OF, Vaidya B, Pearce S, Bassendine MF 2000 CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J Hepatol 32:538-541
171. Harbo HF, Celius EG, Vartdal F, Spurkland A 1999 CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis. Tissue Antigens 53:106-110
172. Seidl C, Donner H, Fischer B, Usadel KH, Seifried E, Kaltwasser JP, Badenhoop K 1998 CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis. Tissue Antigens 51:62-66
173. Djilali-Saiah I, Schmitz J, Harfouch-Hammoud E, Mougenot JF, Bach JF, Caillat-Zucman S 1998 CTLA-4 gene polymorphism is associated with predisposition to coeliac disease. Gut 43:187-189
174. Naluai AT, Nilsson S, Samuelsson L, Gudjonsdottir AH, Ascher H, Ek J, Hallberg B, Kristiansson B, Martinsson T, Nerman O, Sollid LM, Wahlstrom J 2000 The CTLA4/CD28 gene region on chromosome 2q33 confers susceptibility to celiac disease in a way possibly distinct from that of type 1 diabetes and other chronic inflammatory disorders. Tissue Antigens 56:350-355
175. Pullmann Jr R, Lukac J, Skerenova M, Rovensky J, Hybenova J, Melus V, Celec S, Pullmann R, Hyrdel R 1999 Cytotoxic T lymphocyte antigen 4 (CTLA-4) dimorphism in patients with systemic lupus erythematosus. Clin Exp Rheumatol 17:725-729
176. Huang D, Liu L, Noren K, Xia SQ, Trifunovic J, Pirskanen R, Lefvert AK 1998 Genetic association of Ctla-4 to myasthenia gravis with thymoma. J Neuroimmunol 88:192-198
177. Demaine A, Welsh KI, Hawe BS, Farid NR 1987 Polymorphism of the T cell receptor β-chain in Graves' disease. J Clin Endocrinol Metab 65:643-646
178. Mangklabruks A, Cox N, DeGroot LJ 1991 Genetic factors in autoimmune thyroid disease analyzed by restriction fragment length polymorphisms of candidate genes. J Clin Endocrinol Metab 73:236-244
179. Pickerill AP, Watson PF, Tandon N, Weetman AP 1993 T cell receptor β chain gene polymorphisms in Graves' disease. Acta Endocrinol (Copenh) 128:499-502
180. Blakemore AI, Watson PF, Weetman AP, Duff GW 1995 Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J Clin Endocrinol Metab 80:111-115
181. Cuddihy RM, Bahn RS 1996 Lack of an association between alleles of interleukin-1 α and interleukin-1 receptor antagonist genes and Graves' disease in a North American Caucasian population. J Clin Endocrinol Metab 81:4476-4478
182. Muhlberg T, Kirchberger M, Spitzweg C, Herrmann F, Heberling HJ, Heufelder AE 1998 Lack of association of Graves' disease with the A2 allele of the interleukin-1 receptor antagonist gene in a white European population. Eur J Endocrinol 138:686-690
183. Heward J, Allahabadia A, Gordon C, Sheppard MC, Barnett AH, Franklyn JA, Gough SC 1999 The interleukin-1 receptor antagonist gene shows no allelic association with three autoimmune diseases. Thyroid 9:627-628
184. Heward JM, Nithiyananthan R, Allahabadia A, Gibson S, Franklyn JA, Gough SC 2001 No association of an interleukin-4 gene promoter polymorphism with Graves' disease in the United Kingdom. J Clin Endocrinol Metab 86:3861-3863
185. Siegmund T, Usadel KH, Donner H, Braun J, Walfish PG, Badenhoop K 1998 Interferon-γ gene microsatellite polymorphisms in patients with Graves' disease. Thyroid 8:1013-1017
186. Ban Y, Ban Y, Taniyama M, Katagiri T 2000 Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease. Thyroid 10:475-480
187. Bohr UR, Behr M, Loos U 1993 A heritable point mutation in an extracellular domain of the TSH receptor involved in the interaction with Graves' immunoglobulins. Biochim Biophys Acta 1216:504-508
188. Bahn RS, Dutton CM, Heufelder AE, Sarkar G 1994 A genomic point mutation in the extracellular domain of the thyrotropin receptor in patients with Graves' ophthalmopathy. J Clin Endocrinol Metab 78:256-260
189. Cuddihy RM, Dutton CM, Bahn RS 1995 A polymorphism in the extracellular domain of the thyrotropin receptor is highly associated with autoimmune thyroid disease in females. Thyroid 5:89-95
190. Watson PF, French A, Pickerill AP, McIntosh RS, Weetman AP 1995 Lack of association between a polymorphism in the coding region of the thyrotropin receptor gene and Graves' disease. J Clin Endocrinol Metab 80:1032-1035
191. Kotsa KD, Watson PF, Weetman AP 1997 No association between a thyrotropin receptor gene polymorphism and Graves' disease in the female population. Thyroid 7:31-33
192. Allahabadia A, Heward JM, Mijovic C, Carr-Smith J, Daykin J, Cockram C, Barnett AH, Sheppard MC, Franklyn JA, Gough SC 1998 Lack of association between polymorphism of the thyrotropin receptor gene and Graves' disease in United Kingdom and Hong Kong Chinese patients: Case control and family-based studies. Thyroid 8:777-780
193. Imrie H, Vaidya B, Perros P, Kelly WF, Toft AD, Young ET, Kendall-Taylor P, Pearce SHS 2001 Evidence for a Graves' disease susceptibility locus at chromosome Xp11 in a UK population. J Clin Endocrinol Metab 86:626-630
194. de Roux N, Shields DC, Misrahi M, Ratanachaiyavong S, McGregor AM, Milgrom E 1996 Analysis of the thyrotropin receptor as a candidate gene in familial Graves' disease. J Clin Endocrinol Metab 81:3483-3486
195. Tassi V, Scarnecchia L, Di Cerbo A, Pirro MT, Di Paola R, Liuzzi A, Torlontano M, Zingrillo M, D'Aloiso L, De Filippis V 1995 A thyroid hormone receptor β gene polymorphism associated with Graves' disease. Mol Endocrinol 15:267-272
196. Pirro MT, De Filippis V, Di Cerbo A, Scillitani A, Liuzzi A, Tassi V 1995 Thyroperoxidase microsatellite polymorphism in thyroid diseases. Thyroid 5:461-464
197. Tomer Y, Greenberg DA, Concepcion E, Ban Y, Davies TF 2002 Thyroglobulin is a thyroid specific gene for the familial autoimmune thyroid diseases. J Clin Endocrinol Metab 87:404-407
198. Risch N 1990 Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet 46:229-241
199. Tomer Y, Barbesino G, Greenberg DA, Concepcion E, Davies TF 1998 A new Graves disease-susceptibility locus maps to chromosome 20q11.2. Am J Hum Genet 63:1749-1756
200. Lander E, Kruglyak L 1995 Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results. Nat Genet 11:241-247
201. Pearce SHS, Vaidya B, Imrie H, Perros P, Kelly WF, Toft AD, McCarthy MI, Young ET, Kendall-Taylor P 1999 Further evidence for a susceptibility locus on chromosome 20q13.11 in families with dominant transmission of Graves' disease. Am J Hum Genet 65:1462-1465
202. Vaidya B, Imrie H, Perros P, Young ET, Kelly WF, Carr D, Large DM, Toft AD, Kendall-Taylor P, Pearce SHS 2000 Evidence for a new Graves disease susceptibility locus at chromosome 18q21. Am J Hum Genet 66:1710-1714
203. Morahan G, Huang D, Ymer SI, Cancilla MR, Stephen K, Dabadghao P, Werther G, Tait BD, Harrison LC, Colman PG 2001 Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat Genet 27:218-221
204. Merriman T, Twells R, Merriman M, Eaves I, Cox R, Cucca F, McKinney P, Shield J, Baum D, Bosi E, Pozzilli P, Nistico L, Buzzetti R, Joner G, Ronningen K, Thorsby E, Undlien D, Pociot F, Nerup J, Bain S, Barnett A, Todd J 1997 Evidence by allelic association-dependent methods for a type 1 diabetes polygene (IDDM6) on chromosome 18q21. Hum Mol Genet 6:1003-1010
205. Merriman TR, Cordell HJ, Eaves IA, Danoy PA, Coraddu F, Barber R, Cucca F, Broadley S, Sawcer S, Compston A, Wordsworth P, Shatford J, Laval S, Jirholt J, Holmdahl R, Theofilopoulos AN, Kono DH, Tuomilehto J, Tuomilehto-Wolf E, Buzzetti R, Marrosu MG, Undlien DE, Ronningen KS, Ionesco-Tirgoviste C, Shield JP, Pociot F, Nerup J, Jacob CO, Polychronakos C, Bain SC, Todd JA 2001 Suggestive evidence for association of human chromosome 18q12-q21 and its orthologue on rat and mouse chromosome 18 with several autoimmune diseases. Diabetes 50:184-194